Stock Events

Rockwell Medical 

€1.68
51
-€0.04-2.38% Friday 06:03

Statistics

Day High
1.68
Day Low
1.68
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
48.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.48
-0.31
-0.15
0.02
Expected EPS
-0.04
Actual EPS
-0.02

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RWMA.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Show more...
CEO
Dr. Mark Strobeck Ph.D.
Employees
237
Country
US
ISIN
US7743743004
WKN
000A3DL8F

Listings